blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP4363449

EP4363449 - METHODS AND COMPOSITIONS FOR TREATING CANCER [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  05.04.2024
Database last updated on 03.08.2024
FormerThe international publication has been made
Status updated on  06.01.2023
Formerunknown
Status updated on  26.08.2022
Most recent event   Tooltip05.04.2024Publication in section I.1 EP Bulletinpublished on 08.05.2024  [2024/19]
05.04.2024The date on which the examining division becomes responsible, has been established 
05.04.2024Request for examination filedpublished on 08.05.2024  [2024/19]
Applicant(s)For all designated states
GENENTECH, INC.
1 DNA Way
South San Francisco, CA 94080 / US
For all designated states
F. Hoffmann-La Roche AG
Grenzacherstrasse 124
4070 Basel / CH
[2024/19]
Inventor(s)01 / MARKERT, Christoph
82377 Penzberg / DE
02 / MENG, Raymond, D.
South San Francisco, CA 94080-4990 / US
03 / MUECKE, Merlind
4070 Basel / CH
04 / SEN, Shiraj
South San Francisco, CA 94080-4990 / US
05 / TEICHGRAEBER, Volker
4070 Basel / CH
06 / WIEBKING, Volker, Andreas
South San Francisco, CA 94080-4990 / US
07 / CHA, Edward, Namserk
South San Francisco, CA 94080-4990 / US
08 / COTTER, Christopher, Roland
South San Francisco, CA 94080-4990 / US
09 / DORAL, Michelle, Yuri
South San Francisco, CA 94080-4990 / US
 [2024/19]
Representative(s)Klostermeyer-Rauber, Dörte, et al
F. Hoffmann-La Roche AG Corporate Law Patents (CLP) Grenzacherstrasse 124
4070 Basel / CH
[2024/19]
Application number, filing date22755374.001.07.2022
[2024/19]
WO2022US73365
Priority number, dateUS202163218194P02.07.2021         Original published format: US 202163218194 P
US202163226714P28.07.2021         Original published format: US 202163226714 P
US202163286525P06.12.2021         Original published format: US 202163286525 P
[2024/19]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2023279092
Date:05.01.2023
Language:EN
[2023/01]
Type: A2 Application without search report 
No.:EP4363449
Date:08.05.2024
Language:EN
The application published by WIPO in one of the EPO official languages on 05.01.2023 takes the place of the publication of the European patent application.
[2024/19]
Search report(s)International search report - published on:EP16.03.2023
ClassificationIPC:C07K16/28, A61P35/00, C07K16/18, A61K39/00, A61P31/00, A61P35/02
[2024/19]
CPC:
A61P35/00 (EP,IL,KR); A61K39/0011 (EP,IL); C07K16/2803 (EP,IL,KR);
A61K39/12 (EP,IL); A61P31/00 (EP,IL); A61P35/02 (EP,IL);
C07K16/2818 (EP,IL,KR); A61K2039/505 (EP,IL,KR); A61K2039/507 (EP,IL);
A61K2039/5254 (EP,IL); A61K2039/54 (EP,IL,KR); A61K2039/545 (EP,IL,KR);
C07K2317/31 (EP,IL,KR); C12N2760/16134 (EP,IL) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2024/19]
Extension statesBANot yet paid
MENot yet paid
Validation statesKHNot yet paid
MANot yet paid
MDNot yet paid
TNNot yet paid
TitleGerman:VERFAHREN UND ZUSAMMENSETZUNGEN ZUR BEHANDLUNG VON KREBS[2024/19]
English:METHODS AND COMPOSITIONS FOR TREATING CANCER[2024/19]
French:MÉTHODES ET COMPOSITIONS POUR LE TRAITEMENT DU CANCER[2024/19]
Entry into regional phase02.02.2024National basic fee paid 
02.02.2024Designation fee(s) paid 
02.02.2024Examination fee paid 
Examination procedure18.12.2023Amendment by applicant (claims and/or description)
02.02.2024Examination requested  [2024/19]
02.02.2024Date on which the examining division has become responsible
Fees paidRenewal fee
15.03.2024Renewal fee patent year 03
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[Y]WO2018185043  (HOFFMANN LA ROCHE [CH], et al);
 [I]EP3392276  (JIANGSU ALPHAMAB BIOPHARMACEUTICALS CO LTD [CN], et al);
 [XI]WO2020081928  (BRISTOL MYERS SQUIBB CO [US]);
 [Y]WO2020251187  (GREEN CROSS CORP [KR], et al);
 [Y]WO2021043206  (BIO THERA SOLUTIONS LTD [CN]);
 [XI]WO2021133653  (MACROGENICS INC [US]);
 [XP]WO2021154761  (GENENTECH INC [US], et al);
by applicantUS4816567
 WO8906692
 EP0404097
 WO9219579
 WO9301161
 WO9316185
 WO9410202
 WO9429351
 WO9429350
 WO9527062
 US5500362
 WO9627011
 WO9630046
 US5571894
 US5587458
 US5624821
 US5648260
 US5731168
 US5804396
 US5821337
 WO9845332
 WO9850431
 US5869046
 US6054297
 US6171586
 US6248516
 US6267958
 EP0666868
 US6582959
 US2003190317
 US2003203409
 US2003206899
 US6703020
 US6737056
 US2004132028
 WO2004056312
 US6818418
 US2005014934
 WO2005012359
 US6884879
 US2005112126
 WO2005056764
 US2005186208
 US2005260186
 US2006009360
 EP1641818
 WO2006044908
 US7060269
 WO2006121168
 WO2007005874
 US7166697
 US7250297
 US2007224633
 WO2007110205
 EP1870459
 WO2007147901
 US7332581
 US7371826
 US2008139791
 WO2008098796
 WO2009080252
 WO2009080253
 WO2009089004
 WO2009114335
 WO2009126688
 WO2010027827
 US7695936
 WO2010077634
 WO2010129304
 WO2011066389
 WO2011066342
 WO2011090754
 WO2011090762
 WO2011143545
 WO2011161699
 WO2012058768
 US8217149
 WO2012130831
 WO2012145493
 WO2012168944
 US2013034559
 WO2013096291
 WO2013132317
 WO2013144704
 WO2013157954
 WO2013157953
 WO2013181634
 WO2014179664
 WO2014194302
 WO2014206107
 WO2015033301
 WO2015033299
 WO2015033303
 WO2015036927
 WO2015035606
 WO2015044900
 WO2015085847
 WO2015112800
 WO2015112805
 WO2015112900
 US2015210769
 WO2015119930
 WO2015119923
 WO2015150447
 US9205148
 WO2016000619
 WO2016020309
 WO2016032927
 US2016108123
 WO2016061142
 WO2016089873
 WO2016106160
 US9499596
 US20010236388
 WO2016EP73408
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.